SB INVESTMENT ADVISERS (UK) LTD
Follow13F filer, CIK 1731509, LONDON, United Kingdom
SB INVESTMENT ADVISERS (UK) LTD reported $7,662,358,625 across 9 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-14.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001493152-26-038416
- Period
- 2026-06-30
- Reported value
- $7.66B
- Holdings
- 9
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 1
Part of the filer group SB INVESTMENT ADVISERS (UK) LTD
How groups are builtLargest buys vs the previous quarter
None.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| ROIVexited | -2,671,732 | -$74M |
| AURreduced | -5,532,687 | -$37.7M |
| COMPreduced | -500,000 | -$6.17M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q2 2026
Share positions as resolved from 13F-HR 0001493152-26-038416, largest first. % of portfolio is the value over $7,662,358,625, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| CPNGCOUPANG INC | 289,542,259 | $5.03B | 65.64% | 0 | Timeline | ||
| GRABGRAB HOLDINGS LIMITED | 401,796,672 | $1.51B | 19.77% | 0 | Timeline | ||
| RLAYRELAY THERAPEUTICS INC | 27,904,963 | $522M | 6.81% | 0 | Timeline | ||
| COMPCOMPASS INC | 21,504,702 | $265M | 3.46% | -500,000 | Timeline | ||
| VIRVIR BIOTECHNOLOGY INC | 10,948,093 | $112M | 1.46% | 0 | Timeline | ||
| AURAURORA INNOVATION INC | 14,279,073 | $97.4M | 1.27% | -5,532,687 | Timeline | ||
| NRGVENERGY VAULT HOLDINGS INC | 15,535,631 | $73.2M | 0.95% | 0 | Timeline | ||
| YMMFULL TRUCK ALLIANCE CO LTD | 5,272,390 | $42.8M | 0.56% | 0 | Timeline | ||
| DNAGINKGO BIOWORKS HOLDINGS INC | 610,729 | $6.05M | 0.08% | 0 | Timeline |
Sold out in Q2 2026
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| ROIVROIVANT SCIENCES LTD | 2,671,732 | $74M | shares |
How Q2 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001493152-26-038416 | base | 2026-08-14 | acceptance time not in the bulk data set |